IMPACT Therapeutics has received the China National Medical Products Administration (NMPA) marketing authorisation for ...

A nurse, foster mom and the primary provider for a family of eight, Shelly Sepulveda has devoted her life to taking care of ...

A new pathway to fast track patients from the Preston area with suspected ovarian cancer is being implemented at the Royal ...

Over 40% of cancers are linked to lifestyle factors. Learn how simple habits can reduce your cancer risk and improve your ...

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...

Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, is pleased to announce that ...

The Ovarian Cancer Research Alliance (OCRA) proudly announces the extraordinary success of its 2024 year-end fundraising campaign, surpassing its $2 million goal and marking a transformative milestone ...

There are other ways to evaluate ovarian cancer patients beyond radiology ... remains responsible for the patient’s diagnosis and treatment." Epstein noted that AI should only be used as a ...

Eterna Therapeutics (Nasdaq: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today announced positive results from a ...